One of the greatest challenges in regenerative medicine is generating clinically-relevant engineered tissues with functional blood vessels. Vascularization is a key hurdle faced in designing tissue constructs larger than the in vivo limit of oxygen diffusion. In this study, we utilized fibrin-based hydrogels as a foundation for vascular formation, poly(ethylene glycol) (PEG) to modify fibrinogen and increase scaffold longevity, and human amniotic fluid-derived stem cells (AFSC) as a source of vascular cell types (AFSC-EC). AFSC hold great potential for use in regenerative medicine strategies, especially those involving autologus congenital applications, and we have shown previously that AFSC-seeded fibrin-PEG hydrogels have the potential to form three-dimensional vascular-like networks in vitro. We hypothesized that subcutaneously injecting these hydrogels in immunodeficient mice would both induce a fibrindriven angiogenic host response and promote in situ AFSC-derived neovascularization. Two weeks post-injection, the average maximum invasion distance of host murine cells into the subcutaneous fibrin/PEG scaffold was 147±90µm after one week and 395±138µm after two weeks, the average number of cell-lined lumen per mm 2 was significantly higher in hydrogels 
One of the greatest challenges in regenerative medicine is generating clinically-relevant engineered tissues thicker than a few millimeters. The inability to provide functional vascularization is a key hurdle faced in designing tissue constructs larger than the in vivo limit of oxygen, nutrient, and waste diffusion, which is approximately 200 microns. [1] [2] [3] The lack of a rapidly developed vascular network in tissues beyond this limit will result in inadequate in vivo perfusion, increased hypoxia, and decreased cellular viability. [4] [5] [6] Methods of ensuring perfusion in engineered tissues range from stimulating angiogenesis through the introduction of growth factors or biological materials that promote invasion of endogenous host capillaries, [7] [8] [9] to pre-forming vascular networks within scaffolds in vitro prior to implantation. [10] [11] [12] Relying solely on spontaneous or chemotaxis-driven angiogenesis, which vary from tenths of a micron per day to several microns per hour, [13, 14] is generally not sufficient to achieve rapid and complete vascularization of thick constructs. [3, 7, 8] Alternatively, prevascularizing engineered tissues with exogenous cells provides well-formed vascular-like networks prior to implantation. [10, 12, 15] While some studies have shown that seeding endothelial cells into tissue constructs before implantation may improve in vivo perfusion and cell viability, [1, 16, 17] others have shown no difference between the rate of in vivo blood vessel formation in hydrogels pre-vascularized with endothelial cells in vitro compared to mesenchymal stem cell (MSC)-seeded hydrogels relying on in situ vascularization alone. [18] Studies have also shown that combining both endothelial cells and a perivascular cell source, such as MSCs or fibroblasts, is essential in the generation of robust functional vascular networks in vivo. [19] [20] [21] F o r P e e r R e v i e w 4 One potential source of both endothelial and perivascular cell types is amniotic fluidderived stem cells (AFSC). [22] [23] [24] Previous results from our lab suggest that AFSC in threedimensional co-cultures act as a perivascular support cell source similar to MSC and that AFSCderived endothelial cells (AFSC-EC) promote vascular network formation similar to mature endothelial cell. [25] Significant advantages to using AFSC in regenerative medicine strategies include broad differentiation capacity, rapid proliferation, and the potential for use in autologous therapies in neonates, such as an engineered cardiovascular patch for repair of congenital heart defects. [26, 27] In addition to a source of vascular cell types, a suitable scaffold for the development of vascularization is critical. [28] Our laboratory has shown previously that fibrin/poly(ethylene glycol) (PEG) hydrogels provide a platform for cell encapsulation that promotes biocompatibility, mechanical stability, and vasculogenesis. [25] Fibrin is a versatile biopolymer that has a critical role in blood clotting, cellular-matrix interactions, wound healing, and angiogenesis, [29] [30] [31] and is widely used as a biomaterial for engineered adipose, dermal, and cardiovascular tissues. [32] [33] [34] Like most other natural materials though, the main disadvantages of using fibrin as a scaffold are low mechanical stiffness and rapid degradation, [35, 36] both of which can be mitigated by incorporation of PEG, an FDA-approved polymer with a wide range of medical and industrial applications. [25, 37, 38] Based on this data, we hypothesized that subcutaneously injecting AFSC-seeded fibrin/PEG hydrogels in immunodeficient mice would both induce a fibrin-driven angiogenic response and promote AFSC-derived neovascularization. In this study, we evaluated the potential for in situ formation of clinically relevant vasculature by assessing the rate of host cell F o r P e e r R e v i e w 5 invasion, the degree of cell-lined lumen formation, and the co-localization of vascular cell types within AFSC-seeded fibrin/PEG hydrogels.
MATERIALS AND METHODS

Isolation of Human AFSC
Primary human amniotic fluid (AF) was obtained from patients in their second trimester undergoing planned amnioreduction as part of a therapeutic treatment for twin-twin transfusion syndrome (TTTS) as previously described. [22, 39] The experimental protocol and informed consent forms were approved by the Institutional Review Boards of Baylor College of Medicine and Rice University.
Briefly, AF was centrifuged and collected cells were resuspended in modified α-Minimum Essential Media: 63% αMEM (Invitrogen, Carlsbad, CA), 18% Chang Basal Medium (Irvine Scientific, Santa Ana, CA), 2% Chang C supplement (Irvine Scientific), 15% fetal bovine serum (PAA Laboratories, Dartmouth, MA), and GlutaMAX (Invitrogen) at 37°C and 5% CO 2 in a humidified environment. Cells were passaged at 60-70% confluency, and AFSC were isolated through fluorescence-activated cell sorting for expression of the membrane receptor CD117/c-kit (1:100 antibody concentration, BD Biosciences, Bedford, MA; Dako-Cytomation MoFlo sterile cell sorter).
Endothelial Differentiation of AFSC
AFSC were differentiated into endothelial-like cells as previously described. [22] Briefly, c-kit + AFSC at passage 4 were plated at 3000 cells/cm 2 on gelatin-coated plates, allowed to attach for 24 hours in modified αMEM, then cultured in Endothelial Growth Media 2 (EGM-2; 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43 The microstructure of fibrin/PEG hydrogels was analyzed using scanning electron microscopy (Nova NanoSEM 230; FEI, Hillsboro, OR). Hydrogels were fixed in 4% paraformaldehyde (Alfa Aesar, Ward Hill, MA), dehydrated using serial dilution in ethanol (EX0276-3; Millipore), and dried using a critical point dryer (K850; EMI Tech Inc., Fall River, MA). Samples were sputter-coated (208HR; Cressington Scientific, Watford, England, UK) with a 5nm thick layer of platinum, and SEM images were taken between 5.0-7.0 keV and 5-15k magnification using xT Microscope Control software (FEI).
PEGylation Rate
To assess the effect of reaction time on the PEGylation of fibrinogen, 80 mg/mL fibrinogen was combined 1:1 with 8 mg/mL PEG and incubated at 37°C for various lengths of time (0, 1, 5, 20 minutes; 1, 6, 24 hours). At this point, the ester-amine reaction between PEG and fibrinogen was quenched using 50 mM tris[hydroxymethyl]aminomethane (Tris, 161-0716, Bio-Rad, Hercules, CA), and samples were denatured using β-marcaptoethanol (161-0710, Bio- Rad) and boiling for 5 minutes. The samples were electrophoresed by 0.1% sodium dodecyl sulfate-polyacrylamide gel electrophoresis through 4-15% Mini-PROTEAN precast polyacrylamide gels (456-1083, Bio-Rad) at 100 V for 1.5 hours. Gels were stained with 0.125%
Coomassie Brilliant Blue R-250 (20278, Thermo Scientific, Rockford, IL) in 40% methanol and 10% glacial acetic acid overnight, then destained for 24 hours in 20% methanol and 5% glacial acetic acid. Gels were rinsed with deionized water, and then scanned using a Gel Doc XR+ System (Bio-Rad) with automatic exposure adjustment.
Subcutaneous Injection of Fibrin/PEG Hydrogels
In vivo vascularization of fibrin/PEG hydrogels was assessed through subcutaneous implantation in aythymic nude mice in an experimental protocol approved by the Animal Care 10 user to digitally outline the edge of hydrogel, ask the user to click on any number of cells (we selected 50+ cells furthest in to each sample), and then calculate the closest distance in µm from each cell to the hydrogel boundary and averages them.
Fibrin/PEG Hydrogel Analysis
Analysis of Lumen Formation
Similarly, merged high-resolution images of cell-seeded hydrogel sections were analyzed using MATLAB to assess the degree of lumen formation. Though many small areas of the hydrogel sections show degraded scaffold or cell structures in circular patterns, "lumen" was defined in this study as completely cell-lined, scaffold-free areas within the hydrogel. Image file names were blinded to the user, then an .m file was created to ask the user to digitally outline an area of the hydrogel to assess for vascularization, ask the user to click on any number of cells (we selected all lumenal structures in each given area), and then calculate the number of lumen per selected area in lumen/mm 2 and average them.
Immunostaining for Vascular Cell Types
To observe the organization of vascular cell types within the fibrin/PEG implants, slides were rehydrated, treated for antigen retrieval (heat-mediated, citrate-buffered retrieval; ab973, 
RESULTS
Characterization of Fibrin/PEG Hydrogels SEM images display thin fibril structures within fibrin-only hydrogels and larger bundled structures within fibrin/PEG hydrogels. (Fig 1A) Pores throughout individual samples were not uniform in size, but porosity in fibrin-only hydrogels was significantly greater than fibrin/PEG hydrogels (81.7%±6.51% vs 70.7%±8.17, respectively). (Fig 1B) Fibrinogen samples were PEGylated at a 10:1 molar ratio of PEG:fibrinogen at time points ranging from 1 minute to 24 hours. (Fig 1C) Quantification of gel electrophoresis data was done using the Gel Analysis feature within ImageJ. (Fig 1D) 
Subcutaneous Injection of Fibrin/PEG Hydrogels
Hydrogels subcutaneously injected on the dorsal side of an athymic nude mouse were clearly intact two weeks post-implantation. (Fig 2A/B) Explanted control hydrogels without cellseeding were explanted at 1 and 2 weeks post-injection then fixed, paraffin sectioned, and stained with hematoxylin and eosin. Host cell invasion can clearly been seen in high-resolution images. (Fig 2D) Based on these controls, the average maximum distance of host cell infiltration in to the subcutaneous fibrin/PEG scaffold was calculated to be 147.2±90.1µm after one week and 394.8±137.7µm after two weeks. (Fig 2C) Cell-seeded hydrogels were explanted at 2 weeks post-injection, then fixed, sectioned, and H&E stained. (Fig 3A-D ) Slides scanned at 2x showed qualitative differences between samples, such as the large vascular structures seen in (Fig 3D) , while imaged taken at 10x revealed smaller erythrocyte-filled lumen in other samples (Fig 3A) .
Assessment of Hydrogel Vascularization
The degree of lumen formation was determined by comparing the number of cell-lined vessels per mm 2 in sections of various cell-seeded hydrogels. The average density of cell-lined vessels (in lumen per mm 2 ) was significantly higher in hydrogels seeded with stem cells or co- CD31-positive and αSMA-positive cells. Select areas of cell-seeded hydrogels contained dualpositive CD31/α-SMA lumen, whereas no cell control did not. (Fig 4B/C) 
DISCUSSION
The first use of amniotic fluid as a diagnostic tool for genetic abnormalities was in 1956, yet only recently has it been explored for stem and progenitor cell populations. [24, 42, 43] AFSC have since been shown to be a significant source of vascular cell types and have the potential for use in regenerative medicine strategies, such as engineered skeletal/cardiac muscle, tendons, heart valves, and blood vessels. [24, [43] [44] [45] [46] This study expands on our previous work assessing the in vitro vasculogenic potential of AFSC within a three-dimensional fibrin/PEG scaffold. [25] A subcutaneous model was chosen for in vivo evaluation in order to facilitate in situ polymerization of fibrin-based hydrogels and minimize the trauma associated with alternative methods of vascular assessment, such as those that create a pocket between the fascia and muscle. [47] [49] and the driving factor is hypothesized to be the hydrolysis half life of the reactive ester group on this PEG variant, which ranges from 10 minutes to 4 hours. [38, 53] Control hydrogels without cells injected in this murine model showed host cell infiltration on the order of 20-25 µm/day, which is in agreement with reported values of PEG/fibrin hydrogels with similar fibrinogen concentrations. [48] A subpopulation of invading cells stained positive for αSMA, suggesting proliferation and migration of fibroblasts from the underlying fascia layer.
When analyzing the degree of lumen formation within cell-seeded hydrogel sections, as well as the presence of red blood cells, a large degree of variability was seen. A number of factors could play an important role in these results, including injection placement, underlying vascular networks, and inherent animal variability. One significant result was that hydrogels containing MSCs or AFSCs either alone or in co-cultures produced significantly more lumen formation compared to endothelial cell-types alone. Based on our in vitro data in similar hydrogels, [25] we had hypothesized that the development of robust vasculature would require the presence of both exogenous endothelial and perivascular cell sources; however, in similar subcutaneous mouse studies, vascularization was not significantly different between fibrin-based constructs seeded with MSC/HUVEC co-cultures compared to those seeded with MSC only. [18] Recent insight in to the secretome of AFSCs may help explain these results. Paracrine factors produced by AFSCs, including vascular endothelial growth factor, stromal cell-derived factor 1, interleukin 8, and monocyte chemotactic protein 1, were isolated and shown to be capable of enhancing vasculogenesis in a murine model. [54] This combination of pro-angiogenic cytokines has a clear effect on the recruitment of endothelial cell types specifically [55] and could mask the effects seen by introducing exogenous vascular cells. [56] In this study, in situ vascularization of subcutaneously injected fibrin/PEG hydrogels was clearly correlated to the presence of a stem cell source, either AFSC or MSC; however, in order to understand the role that AFSC and AFSC-EC play in in vivo vessel formation, further analysis is required. Determining the localization of exogenous cells in both the bulk of the hydrogel and in relation to the formation of dual-positive CD31/αSMA lumen will be critical to assessing the therapeutic potential of AFSC-derived vascularization. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Explanted no cell control and AFSC/AFSC-EC co-culture hydrogels at 2 week post-injection. Scale bars are 5mm. Explants were fixed and paraffin sectioned, then stained with hematoxylin and eosin to assess general morphology. Samples were scanned at 2x (shown), as well as imaged at 10x and digitally merged for analysis. Representative images of (C) AFSC-only, (D) AFSC-EC-only, (E) AFSC/AFSC-EC, and (F) MSC/HUVEC-seeded hydrogels explanted at 2 weeks then H&E stained.
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